We assign a fundamental rating of 2 out of 10 to CLNN. CLNN was compared to 525 industry peers in the Biotechnology industry. CLNN may be in some trouble as it scores bad on both profitability and health. CLNN is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CLNN has reported negative net income.
CLNN had a negative operating cash flow in the past year.
In the past 5 years CLNN always reported negative net income.
CLNN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

CLNN has a Return On Assets of -136.69%. This is amonst the worse of the industry: CLNN underperforms 82.10% of its industry peers.

		Industry Rank	Sector Rank
ROA	-136.69%
ROE	N/A
ROIC	N/A

ROA(3y)-101.99%

ROA(5y)-69.93%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of CLNN (82.24%) is better than 85.90% of its industry peers.
In the last couple of years the Gross Margin of CLNN has grown nicely.
The Profit Margin and Operating Margin are not available for CLNN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	82.24%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y10.02%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CLNN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLNN has been increased compared to 1 year ago.
Compared to 5 years ago, CLNN has more shares outstanding
CLNN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -21.14, we must say that CLNN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -21.14, CLNN is doing worse than 83.43% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-21.14

ROIC/WACCN/A

WACC10.01%

2.3 Liquidity

CLNN has a Current Ratio of 1.53. This is a normal value and indicates that CLNN is financially healthy and should not expect problems in meeting its short term obligations.
CLNN has a worse Current ratio (1.53) than 81.14% of its industry peers.
A Quick Ratio of 1.52 indicates that CLNN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.52, CLNN is doing worse than 80.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.53
Quick Ratio	1.52

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CLNN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.20%, which is quite impressive.
CLNN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -49.17%.
Measured over the past years, CLNN shows a very negative growth in Revenue. The Revenue has been decreasing by -21.98% on average per year.

EPS 1Y (TTM)32.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30.33%

Revenue 1Y (TTM)-49.17%

Revenue growth 3Y-21.98%

Revenue growth 5YN/A

Sales Q2Q%-82.76%

3.2 Future

Based on estimates for the next years, CLNN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.58% on average per year.
Based on estimates for the next years, CLNN will show a very strong growth in Revenue. The Revenue will grow by 304.58% on average per year.

EPS Next Y60.08%

EPS Next 2Y27.66%

EPS Next 3Y22.74%

EPS Next 5Y24.58%

Revenue Next Year-57.73%

Revenue Next 2Y-12.27%

Revenue Next 3Y483.93%

Revenue Next 5Y304.58%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLNN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLNN. No positive earnings are expected for the next year.